Doubling of new prescriptions for ADHD medications among adults since start of COVID-19 pandemic

New prescriptions for stimulants among adults, largely to treat ADHD, have more than doubled since the start of the COVID-19 pandemic, especially in younger adults, finds new research published in CMAJ (Canadian Medical Association Journal).